PharmaCorp Rx Inc. (TSXV:PCRX)

Revenue by Segment

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
Non-wholly Owned Pharmacies	2.99M	1.00
Non-wholly Owned Pharmacies Growth	299055800.00%	-
Wholly Owned Pharmacies	2.80M	-
Total	5.79M	1.00
Total Growth	579491300.00%	-

Revenue by Geography

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2024
Period Ending	Dec 31, 2024
Canada	5.79M
Total	5.79M

Source: S&P Global Market Intelligence.